US FDA indicates plans to regulate laboratory-developed tests
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has indicated that it plans to begin regulating laboratory-developed tests (LDTs) in order to assure the public that all in vitro diagnostic tests used in the provision of healthcare, whether developed by a laboratory or by other manufacturers, are safe and effective1,2.